Ami Jo

425 total citations
10 papers, 353 citations indexed

About

Ami Jo is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Ami Jo has authored 10 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Biomaterials, 4 papers in Biomedical Engineering and 3 papers in Molecular Biology. Recurrent topics in Ami Jo's work include Nanoparticle-Based Drug Delivery (4 papers), Graphene and Nanomaterials Applications (2 papers) and PARP inhibition in cancer therapy (2 papers). Ami Jo is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Graphene and Nanomaterials Applications (2 papers) and PARP inhibition in cancer therapy (2 papers). Ami Jo collaborates with scholars based in United States, Japan and South Korea. Ami Jo's co-authors include Richey M. Davis, Irving C. Allen, Veronica M. Ringel‐Scaia, Sheryl Coutermarsh‐Ott, SeungBeum Suh, Bahareh Behkam, Mahama A. Traoré, Ying Zhan, Xia Long and David G. I. Kingston and has published in prestigious journals such as Langmuir, Advanced Science and Protein Science.

In The Last Decade

Ami Jo

8 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ami Jo United States	7	187	106	99	98	54	10	353
Piper A. Rawding United States	8	142 0.8×	40 0.4×	170 1.7×	80 0.8×	21 0.4×	12	383
Mei‐Ting Niu China	12	435 2.3×	122 1.2×	184 1.9×	141 1.4×	161 3.0×	15	670
Rong Sun China	7	197 1.1×	80 0.8×	102 1.0×	57 0.6×	120 2.2×	12	357
Ze‐Nan Zhuang China	9	422 2.3×	167 1.6×	214 2.2×	54 0.6×	159 2.9×	11	643
Muye He China	11	180 1.0×	163 1.5×	133 1.3×	23 0.2×	65 1.2×	24	440
Nahal Habibi United States	9	144 0.8×	157 1.5×	143 1.4×	20 0.2×	49 0.9×	11	359
Jianquan Wang China	13	203 1.1×	140 1.3×	310 3.1×	22 0.2×	109 2.0×	28	610
Andrea Patrizia Falanga Italy	14	116 0.6×	88 0.8×	225 2.3×	12 0.1×	65 1.2×	39	476
Marjorie T. Buss United States	6	276 1.5×	22 0.2×	107 1.1×	133 1.4×	38 0.7×	9	422
Zhaoqing Cong China	13	355 1.9×	239 2.3×	227 2.3×	22 0.2×	79 1.5×	26	681

Countries citing papers authored by Ami Jo

Since Specialization

Citations

This map shows the geographic impact of Ami Jo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ami Jo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ami Jo more than expected).

Fields of papers citing papers by Ami Jo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ami Jo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ami Jo. The network helps show where Ami Jo may publish in the future.

Co-authorship network of co-authors of Ami Jo

This figure shows the co-authorship network connecting the top 25 collaborators of Ami Jo. A scholar is included among the top collaborators of Ami Jo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ami Jo. Ami Jo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Shoji, Tadahiro, Ami Jo, Sho Sato, et al.. (2025). Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective Study. Anticancer Research. 45(12). 5773–5783.

Jo, Ami, et al.. (2025). Treatment strategies for advanced and recurrent endometrial cancer using immune checkpoint inhibitors. International Journal of Clinical Oncology. 30(2). 229–240.

Sato, Sho, et al.. (2024). Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer. Cancers. 16(14). 2545–2545. 6 indexed citations

Jo, Ami, Veronica M. Ringel‐Scaia, Dylan K. McDaniel, et al.. (2020). Fabrication and characterization of PLGA nanoparticles encapsulating large CRISPR–Cas9 plasmid. Journal of Nanobiotechnology. 18(1). 16–16. 64 indexed citations

Jo, Ami, et al.. (2018). Design and Fabrication of Streptavidin-Functionalized, Fluorescently Labeled Polymeric Nanocarriers. Langmuir. 34(51). 15783–15794. 6 indexed citations

Fellows, Benjamin, Nikorn Pothayee, Nan Hu, et al.. (2018). Ammonium Bisphosphonate Polymeric Magnetic Nanocomplexes for Platinum Anticancer Drug Delivery and Imaging with Potential Hyperthermia and Temperature-Dependent Drug Release. Journal of Nanomaterials. 2018. 1–14. 1 indexed citations

Suh, SeungBeum, Ami Jo, Mahama A. Traoré, et al.. (2018). Nanoscale Bacteria‐Enabled Autonomous Drug Delivery System (NanoBEADS) Enhances Intratumoral Transport of Nanomedicine. Advanced Science. 6(3). 1801309–1801309. 151 indexed citations

Du, Yongle, Xia Long, Ami Jo, et al.. (2017). Synthesis and Evaluation of Doxorubicin-Loaded Gold Nanoparticles for Tumor-Targeted Drug Delivery. Bioconjugate Chemistry. 29(2). 420–430. 102 indexed citations

Jo, Ami, et al.. (2017). Structural, thermodynamic, and phosphatidylinositol 3‐phosphate binding properties of Phafin2. Protein Science. 26(4). 814–823. 10 indexed citations

10.

McDaniel, Dylan K., Ami Jo, Veronica M. Ringel‐Scaia, et al.. (2016). TIPS pentacene loaded PEO-PDLLA core-shell nanoparticles have similar cellular uptake dynamics in M1 and M2 macrophages and in corresponding in vivo microenvironments. Nanomedicine Nanotechnology Biology and Medicine. 13(3). 1255–1266. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact